Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease-Reference-Cited by-同舟云学术

Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease

Published:1979-01 Issue:1-2 Volume:16 Page:205-217
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Jakubowski J.A.,Ardlie N.G.

Publisher

Elsevier BV

Subject

Hematology

Reference34 articles.

1. Platelets, prostaglandins, red cells, sedimentation rates, serum and tissue proteins and non-steroidal anti-inflammatory drugs;Glenn,1972

2. Biosynthesis of prostaglandin E2 in human platelets from 1-14C-arachidonic acid;Schoene;Circulation,1972

3. Arachidonic acid-induced human platelet aggregation and prostaglandin formation;Silver;Prostaglandins,1973

4. Formation and release of prostaglandins by platelets in response to thrombin;Smith;Brit. J. Pharmacol.,1970

5. Human blood prostaglandins: Formation during clotting;Silver;Prostaglandins,1972

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH;Expert Opinion on Investigational Drugs;2022-12-02

2. Marine-derived n-3 fatty acids therapy for stroke;Cochrane Database of Systematic Reviews;2022-06-29

3. A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH;Journal of Hepatology;2021-12

4. Shear-Mediated Platelet Activation is Accompanied by Unique Alterations in Platelet Release of Lipids;Cellular and Molecular Bioengineering;2021-08-25

5. Shear-Mediated Platelet Activation is Accompanied by Unique Alterations of Platelet Lipid Profile;2021-01-09